Summit Therapeutics
SMMT
SMMT
11 hedge funds and large institutions have $29.5M invested in Summit Therapeutics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
AIC
1
AWM Investment Company
New York
|
$0 |
| 2 |
GPCM
2
Granite Point Capital Management
Boston,
Massachusetts
|
$1.33M |
| 3 |
3
Citigroup
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LPU
1
Lansdowne Partners (UK)
London,
United Kingdom
| $9.68M | 930,000 | – | – |
|
2
Point72 Asset Management
Stamford,
Connecticut
| $9.57M | 919,639 | +7,736 | +0.8% |
|
3
Axa
Paris,
France
| $3.92M | 376,205 | +83,298 | +28% |
|
|
SFM
4
Sphera Funds Management
Tel Aviv,
Israel
| $2.14M | 205,200 | – | – |
|
5
First Eagle Investment Management
New York
| $1.82M | 175,000 | – | – |
|
|
GPCM
6
Granite Point Capital Management
Boston,
Massachusetts
| $1.33M | 127,841 | -316 | -0.2% |
|
|
EAM
7
EverPoint Asset Management
Stamford,
Connecticut
| $1.04M | 100,000 | – | – |
|
8
Wells Fargo
San Francisco,
California
| $26K | 2,500 | +2,500 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $13K | 1,228 | +1,228 | New |
|
10
UBS Group
Zurich,
Switzerland
| $9K | 880 | +680 | +340% |
|
|
AIC
11
AWM Investment Company
New York
| – | – | -42,693 | Closed |
|
|
12
Citigroup
New York
| – | – | -53 | Closed |
|
13
Morgan Stanley
New York
| $0 | 9 | +1 | +13% |
|